---
title: "Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder"
type: pub
---
<h1>Publikasjon</h1>
<article id="csl-bib-container-BTNFFSXK" class="csl-bib-container">
  <div class="csl-bib-body" style="line-height: 1.35; padding-left: 1em; text-indent:-1em;">
  <div class="csl-entry">Bj&#xF8;rklund, G., Meguid, N. A., El-Ansary, A., El-Bana, M. A., Dadar, M., Aaseth, J., Hemimi, M., Osredkar, J., &amp; Chirumbolo, S. (2018). Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder. <i>Journal of Molecular Neuroscience</i>, <i>66</i>(4), 492&#x2013;511. <a href="https://doi.org/10.1007/s12031-018-1192-1">https://doi.org/10.1007/s12031-018-1192-1</a></div>
</div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-BTNFFSXK" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=1628271" alt="Cristin URL" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5022929/items/BTNFFSXK" alt="Zotero URL" class="csl-bib-button">Zotero</a>
    <a href="#abstract-article-BTNFFSXK" class="csl-bib-button">Samandrag</a>
    <a href="http://ezproxy.inn.no/login?url=https://doi.org/10.1007/s12031-018-1192-1" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-BTNFFSXK"></div>
</article>
<div id="csl-bib-meta-BTNFFSXK" class="csl-bib-meta">
  <article id="abstract-article-BTNFFSXK" class="abstract-article">
    <h1>Samandrag</h1>
    Autism spectrum disorder (ASD) is a neurodevelopmental disorder afflicting about one in every 68 children. It is behaviorally diagnosed based on a triad of symptoms, including impairment in communication, impairment in sociability and abnormal and stereotypic behavior. The subjectivity of behavioral diagnosis urges the need for clinical biomarker tests to improve and complement ASD diagnosis and treatment. Over the past two decades, researchers garnered a broad range of biomarkers associated with ASD and often correlating with the severity of ASD, which includes metabolic and genetic biomarkers or neuroimaging abnormalities. Metabolic biomarkers are either involved in key pathways such as a trans-sulfuration pathway or produced due to the derangement of these pathways in the case of oxidative stress. Recent studies reported several genetic abnormalities related to ASD, encompassing various mechanisms, from copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) to chromosomal anomalies. However, it is still premature to consider these genetic variants as true biomarkers for ASD, due to their low reproducibility and regional-specific nature. Herein, we comprehensively review state of the art about major biomarkers reported in ASD and the association of some biomarkers with ASD symptoms and severity. It is important to establish those biomarkers to be able to help in the diagnosis and to optimize the treatment of ASD.
  </article>
  <article id="taxonomy-article-BTNFFSXK" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li>HÃ¸gskolen i Innlandet</li>
      <li>Fakultet for helse- og sosialvitenskap</li>
      <li>Institutt for helse- og sykepleievitenskap</li>
      <li>2018</li>
      <li>November</li>
    </ul>
  </article>
</div>
